India's Biotech Exchange Boom
Biotech trade programs have boosted Indian pharma exports, especially in the vaccine and biosimilar segments. Collaborative R&D initiatives and government incentives have attracted global investors. The sector is expected to see double-digit growth through 2026.
In-depth Details:
The biotech sector’s rapid expansion is fueled by increased funding for research and the establishment of biotech parks across major cities. Government incentives, such as tax breaks and grants, have encouraged startups to innovate in vaccine development and biosimilar production. International partnerships have led to technology transfers and skill development, further enhancing India’s capabilities. The sector’s growth is also supported by a robust regulatory framework and a skilled workforce. Analysts predict that continued investment in R&D and infrastructure will position India as a global leader in biotech exports over the next few years.